miR-21: a non‐specific biomarker of all maladies

Ana E. Jenike, Marc K. Halushka

Research output: Contribution to journalReview articlepeer-review

Abstract

miRNA-21 is among the most abundant and highly conserved microRNAs (miRNAs) recognized. It is expressed in essentially all cells where it performs vital regulatory roles in health and disease. It is also frequently claimed to be a biomarker of diseases such as cancer and heart disease in bodily-fluid based miRNA studies. Here we dissociate its contributions to cellular physiology and pathology from its potential as a biomarker. We show how it has been claimed as a specific predictive or prognostic biomarker by at least 29 diseases. Thus, it has no specificity to any one disease. As a result, it should not be considered a viable candidate to be a biomarker, despite its continued evaluation as such. This theme of multiple assignments of a miRNA as a biomarker is shared with other common, ubiquitous miRNAs and should be concerning for them as well.

Original languageEnglish (US)
Article number18
JournalBiomarker Research
Volume9
Issue number1
DOIs
StatePublished - Dec 2021

Keywords

  • Biomarker
  • cancer
  • Heart disease
  • microRNA
  • miR-21-5p
  • Plasma
  • Serum

ASJC Scopus subject areas

  • Molecular Medicine
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of 'miR-21: a non‐specific biomarker of all maladies'. Together they form a unique fingerprint.

Cite this